Boston Scientific (BSX) Cash Flow Statement

Click line-items for a historical chart and %

Cash provided by operating activities	506M
Purchases of property, plant and equipment, net of proceeds	-209M
Proceeds from sales of publicly traded and privately held equity securities and collections of notes receivable
Payments for acquisitions of businesses, net of cash acquired	-70M
Payments relating to prior period acquisitions
Payments for investments in companies and acquisitions of certain technologies	0
Proceeds from business divestitures, net of costs
Cash provided by (used for) investing activities	-355M
Proceeds from long-term borrowings, net of debt issuance costs
Payments on long-term borrowings	-250M
Proceeds from borrowings on credit facilities	330M
Payments on borrowings from credit facilities	-330M
Proceeds from issuances of shares of common stock	108M
Cash (used for) provided by financing activities	-234M
Effect of Exchange Rate on Cash and Cash Equivalents	1M
Cash and Cash Equivalents, Period Increase (Decrease)	-82M
Cash and cash equivalents at beginning of period	319M
Cash and cash equivalents at end of period	237M
Stock-based compensation expense	87M

Entities mentioned with BSX

View All Entities